XT
RCKT icon

XTX Topco’s Rocket Pharmaceuticals RCKT Stock Holding History

XTX Topco’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.2K Sell
10,288
-167,739
-94% -$558K ﹤0.01% 3792
2026
Q1 		$637K Buy
178,027
+31,627
+22% +$126K 0.01% 1801
2025
Q4 		$514K Sell
146,400
-1,101
-0.7% -$3.77K 0.01% 1577
2025
Q3 		$481K Buy
147,501
+13,056
+10% +$41.1K 0.03% 1105
2025
Q2 		$329K Buy
134,445
+100,038
+291% +$507K 0.01% 1363
2025
Q1 		$229K Sell
34,407
-29,227
-46% -$289K 0.01% 1602
2024
Q4 		$800K Buy
63,634
+48,131
+310% +$725K 0.07% 423
2024
Q3 		$286K Buy
+15,503
New +$318K 0.02% 1219
2024
Q2 		– Sell
-9,507
Closed -$256K – 2366
2024
Q1 		$256K Buy
+9,507
New +$270K 0.03% 983
2023
Q1 		– Sell
-19,859
Closed -$389K – 1594
2022
Q4 		$389K Buy
19,859
+2,746
+16% +$50.6K 0.08% 424
2022
Q3 		$273K Buy
+17,113
New +$267K 0.07% 572

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

XTX Topco's RCKT Position: Q2 2026 in Review

XTX Topco reduced its Rocket Pharmaceuticals (RCKT) stake by 94% in Q2 2026, selling an estimated $558K and leaving 10,288 shares worth $35.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3792.

XTX Topco first reported a position in RCKT in Q3 2022 and has held it in 11 quarters since. The position peaked at $800K in Q4 2024. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • XTX Topco held 10,288 shares of Rocket Pharmaceuticals worth $35.2K as of Q2 2026.
  • XTX Topco sold 167,739 Rocket Pharmaceuticals shares in Q2 2026, an estimated $558K.
  • Rocket Pharmaceuticals made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3792 holding.
  • XTX Topco first reported a position in Rocket Pharmaceuticals in Q3 2022 and has held it in 11 quarters since.
  • XTX Topco's Rocket Pharmaceuticals position peaked at $800K in Q4 2024.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.